Payer Coverage Considerations for Alzheimer Disease Blood-Based Biomarker Tests
This Viewpoint discusses proactively preparing to make informed payer coverage decisions to help address current disparities in Alzheimer disease diagnosis and treatment.
Authors
- Patricia A. Deverka (ORCID: https://orcid.org/0000-0002-1777-4286)
- Grace A. Lin (ORCID: https://orcid.org/0000-0001-6498-641X)
- Kathryn A. Phillips
Institutions
- University of California, San Francisco (US)
- Gad Consulting Services (United States) (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1001/jama.2024.19084
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.39
Funders
- Georgia State University
- National Human Genome Research Institute